Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:enzyme_replacement_therapy
gptkb:drug |
| gptkbp:activeIngredient |
gptkb:alglucosidase_alfa
|
| gptkbp:approvedBy |
gptkb:FDA
gptkb:EMA 2006 |
| gptkbp:ATCCode |
A16AB07
|
| gptkbp:brand |
gptkb:alglucosidase_alfa
|
| gptkbp:CASNumber |
339186-68-8
|
| gptkbp:form |
powder for solution for infusion
|
| gptkbp:indication |
gptkb:lysosomal_storage_disorder
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Sanofi_Genzyme
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:United_States |
| gptkbp:mechanismOfAction |
replaces acid alpha-glucosidase
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
allergic reactions
respiratory complications infusion-related reactions |
| gptkbp:treatment |
gptkb:glycogen_storage_disease_type_II
|
| gptkbp:UNII |
6U8Z330A7M
|
| gptkbp:usedFor |
gptkb:Pompe_disease
|
| gptkbp:bfsParent |
gptkb:Genzyme
gptkb:Genzyme_(2011) gptkb:Sanofi-Aventis gptkb:Sanofi_Aventis |
| gptkbp:bfsLayer |
6
|
| https://www.w3.org/2000/01/rdf-schema#label |
Myozyme
|